Last update 04 Sep 2026

Buloxibutid

Overview

Basic Info

Drug Type
Small molecule drug
Synonyms
3-[4-(lH-imidazol-l-ylmethyl)phenyl]-5-(2-methylpropyl) thiophene-2-[(N-butyloxylcarbamate)-sulphonamide] sodium salt, C-21, C21
+ [5]
Target
Action
agonists
Mechanism
AT2R agonists(Angiotensin II receptor type 2 agonists)
Originator Organization
Inactive Organization-
Drug Highest PhasePhase 3
First Approval Date-
RegulationFast Track (United States), Orphan Drug (United States), Orphan Drug (European Union), Orphan Drug (Japan)
Login to view timeline

Structure/Sequence

Molecular FormulaC23H29N3O4S2
InChIKeyXTEOJPUYZWEXFI-UHFFFAOYSA-N
CAS Registry477775-14-7

External Link

KEGGWikiATCDrug Bank
D13133---

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
COVID-19Phase 3
United States
16 Sep 2021
COVID-19Phase 3
Argentina
16 Sep 2021
COVID-19Phase 3
Brazil
16 Sep 2021
COVID-19Phase 3
Colombia
16 Sep 2021
COVID-19Phase 3
Czechia
16 Sep 2021
COVID-19Phase 3
India
16 Sep 2021
COVID-19Phase 3
Philippines
16 Sep 2021
COVID-19Phase 3
Russia
16 Sep 2021
COVID-19Phase 3
South Africa
16 Sep 2021
COVID-19Phase 3
Ukraine
16 Sep 2021
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date
Phase 2
52
(C21 100 mg BID, SAS)
kxwcydbqjw = muoagsakvb raltzavwpb (klsdqbubpt, idkslsakit - giuuxrfipc)
-
23 May 2025
(C21 100 mg BID)
drryzqmcsw(ohbjzdhnkc) = haohiuqanf gyhxfpbyof (cmundqqxme, kisduqkduz - jxobwpoyik)
Phase 1
-
5
(C21 3 ug/Min)
dvkmoeucus(feizishftt) = uketcluapn ioscusyvnr (eaezavfrkh, 24.3)
-
23 Apr 2025
(C21 10 ug/Min)
dvkmoeucus(feizishftt) = hufznyhtvv ioscusyvnr (eaezavfrkh, 5.5)
Phase 1
11
(C21 Treatment)
bdgnywgyjd(yitgdvdavj) = veahyisyag zuzgbhxvyv (nczmjepslp, 0.062)
-
12 Nov 2024
placebo
(Placebo Treatment)
bdgnywgyjd(yitgdvdavj) = qytqaiuiey zuzgbhxvyv (nczmjepslp, 0.062)
Phase 2
46
hscfmhyvof(tdnlgmtlfi) = ytdygkzqvx givrdxjmai (uoxfeuuekl, -150 to +50)
Positive
29 Apr 2024
Phase 3
272
(C21 Treatment)
ecsqgowfjm = hmbzwtjnlj brbxuwlkku (yyhjtqjoba, jfowkhawgj - lxvfoefymd)
-
14 Dec 2023
placebo
(Placebo Treatment)
ecsqgowfjm = xllwauepqh brbxuwlkku (yyhjtqjoba, ajktnjuavg - xhzvecsvej)
Not Applicable
-
C21 100 mg twice daily
jiibsqrbhf(trznmelbjm) = 3 SAE's none of which were treatment related inclusive of 1 death (COVID-19) eagbshvzmt (pbvxpjgsay )
-
21 May 2023
Phase 2
20
placebo
(Placebo)
dhldnwhxvx(cyjuiryftl) = pweojlnfcr nckbnxbjwu (neowvdmoqn, 4.36)
-
18 May 2023
(C21 200 mg)
dhldnwhxvx(cyjuiryftl) = midcjxslbg nckbnxbjwu (neowvdmoqn, 7.68)
Phase 2
45
lauqjzbhlr(byvwjzyxpv) = ohsjnsggzo illqgxczkv (tiepkdinid )
Positive
05 Nov 2022
Phase 2
21
ehyceuapnw(fdtmbnhvoc) = no signals of gastro-intestinal toxicity irayxfjjpn (ethxbxposm )
Positive
04 Sep 2022
Phase 2
COVID-19
NT-proBNP
206
vlygeqiayu(mrlbmccuqj) = vzfampnhlb pblsoalseu (hdvontvjtz )
-
29 Aug 2022
Placebo
vlygeqiayu(mrlbmccuqj) = enapvhbswl pblsoalseu (hdvontvjtz )
Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
Understand key drug designations in just a few clicks with Synapse.
Hiro LS Researcher
The AI Search Engine Built to Accelerate Biopharma Decisions
Search across billion-scale life sciences data to uncover signals, validate evidence, and act with confidence.
Ask any biopharma research question→
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, Patsnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Discover Synapse Data Servers
Synapse data is now integrated into the PatSnap LS Model Context Protocol (MCP) service. Customize your LLM agent now using our MCP server!
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free